from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0276/-

LFCtreatmentdescriptionclass of inhibitor

-0.914

Amikacinug/mL Amikacintranslation

-0.685

Cap5-10ug/mL Capreomycintranslation

-0.460

Rox10-50 ug/mL Roxithromycintranslation

-0.565

SM2-5 ug/mL Streptomycintranslation

0.314

Tet5-10 ug/mL Tetracyclinetranslation

0.121

Rif0.2-5ug/mL Rifampicintranscription

-0.474

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.078

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.149

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.023

CPZ10-50 ug/mL Chlorpromazinerespiration

0.873

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.214

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.856

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.412

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.916

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.087

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.973

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.241

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.924

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.917

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

3.066

KCN5-20 ug/mL Potassium cyaniderespiration

0.548

NaN30.2-2 mM Sodium aziderespiration

0.351

Nigericin50 uM Nigericinrespiration

0.798

TRC10-150 ug/mL Triclosanrespiration

-1.173

TRZ10-25 ug/mL Thioridazinerespiration

-1.248

Valinomycin0.5-10 uM Valinomycinrespiration

-0.725

ZnSO42 mM ZnSO4respiration

-0.664

menadione6-10 ug/mL Menadionerespiration

0.500

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.122

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.721

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.007

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.123

NRP_1Non-replicating persistence stage 1dosRassociated

-0.268

Amp0.2mg/mL AmpicillincellWall

-0.529

Cephalexin20-100 ug/mL CephalexincellWall

-0.308

Cerulenin0.32-5 ug/mL CerulenincellWall

0.240

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.159

EMB10-20 ug/mL EthambutolcellWall

0.213

Eta12-40 ug/mL EthionamidecellWall

0.058

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.166

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.362

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.018

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.505

BZA0.12 mg/mL BenzamidearomaticAmides

0.293

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.574

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.070

H2O24 mM hydrogen peroxideDNAdamaging

0.115

Levo10 ug/mL LevofloxacinDNAdamaging

-0.603

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.014

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.013

Oflox5-10 ug/mL OfloxacinDNAdamaging

-1.250

UVUV-irradiationDNAdamaging

-0.400

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.007

Antimycin12.5-50 ug/mL Antimycin A?

-0.028

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.398

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.102

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.331

PA8240.2-2 ug/mL PA-824?

2.074

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.145

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.650

Verapamil50 uM Verapamil?

-0.171

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.498

methoxatin10-20 ug/mL Methoxatin?